Prevalence of linezolid-resistant organisms among patients admitted to a tertiary hospital for critical care or dialysis

BACKGROUND: Linezolid is an oxazolidinone antimicrobial regarded as a “last resort” antimicrobial, used typically for treatment of Gram-positive bacterial infections. It is acknowledged that prevalence of resistance to linezolid is increasing in Europe. In Ireland, a number of outbreaks of linezolid...

Descripción completa

Detalles Bibliográficos
Autores principales: Dembicka, Kornelia Maria, Powell, James, O’Connell, Nuala H., Hennessy, Noreen, Brennan, Grainne, Dunne, Colum P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308576/
https://www.ncbi.nlm.nih.gov/pubmed/34505273
http://dx.doi.org/10.1007/s11845-021-02773-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308576/
https://www.ncbi.nlm.nih.gov/pubmed/34505273
http://dx.doi.org/10.1007/s11845-021-02773-2

Ejemplares similares